Friday, September 7, 2012

Vol. 18, No. 17

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 17  September 5, 2012
(The next issue will be on September 17, 2012)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-oN6gQgIZ1PvyvUWhqvfkD/

Ahonen J (2012) The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol 25:309-314.
http://www.ncbi.nlm.nih.gov/pubmed/22473215


Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM (2011) Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One 6:e28578.
http://www.ncbi.nlm.nih.gov/pubmed/22194859

Ben-Hadj-Khalifa S, Lakhal B, Mahjoub T, Almawi WY (2012) Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians. J Thromb Thrombolysis.
http://www.ncbi.nlm.nih.gov/pubmed/22932775

Botianu AM, Demian S, Macarie I, Georgescu D, Oltean G, Bataga S (2012) Acquired haemophilia complicated with gastrointestinal bleeding and spontaneous iliopsoas muscle haematoma in a woman with chronic C hepatitis under treatment with pegylated IFN alpha 2a and ribavirin. J Gastrointestin Liver Dis 21:93-95.
http://www.ncbi.nlm.nih.gov/pubmed/22457865

Carrera-Marin AL, Romay-Penabad Z, Papalardo E, Reyes-Maldonado E, Garcia-Latorre E, Vargas G, . . . Pierangeli S (2012) C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus.
http://www.ncbi.nlm.nih.gov/pubmed/22933620

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS (2012) Factor VII for excessive bleeding following congenital heart disease surgery. Asian Cardiovasc Thorac Ann 20:120-125.
http://www.ncbi.nlm.nih.gov/pubmed/22499956

Cheng J, Xu J, Duanmu J, Zhou H, Booth CJ, Hu Z (2011) Effective treatment of human lung cancer by targeting tissue factor with a factor VII-targeted photodynamic therapy. Curr Cancer Drug Targets 11:1069-1081.
http://www.ncbi.nlm.nih.gov/pubmed/21933104

Darlington DN, Kremenevskiy I, Pusateri AE, Scherer MR, Fedyk CG, Kheirabaldi BS, . . . Dubick MA (2012) Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood. Int J Burns Trauma 2:42-50.
http://www.ncbi.nlm.nih.gov/pubmed/22928166

Etscheid M, Muhl L, Pons D, Jukema JW, Konig H, Kanse SM (2012) The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22906531

Gebhard C, Holy EW, Camici GG, Akhmedov A, Stampfli SF, Stahli BE, . . . Tanner FC (2012) Caffeine induces endothelial tissue factor expression via phosphatidylinositol 3-kinase inhibition. Thromb Haemost 107:884-894.
http://www.ncbi.nlm.nih.gov/pubmed/22437887

Georgescu A, Alexandru N, Andrei E, Titorencu I, Dragan E, Tarziu C, . . . Popov D (2012) Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan. J Thromb Haemost 10:680-691.
http://www.ncbi.nlm.nih.gov/pubmed/22303879

Ghanny S, Warkentin TE, Crowther MA (2012) Reversing anticoagulant therapy. Curr Drug Discov Technol 9:143-149.
http://www.ncbi.nlm.nih.gov/pubmed/22023256

Gopalakrishnan R, Pendurthi UR, Hedner U, Agerso H, Esmon CT, Rao LV (2012) Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa. J Thromb Haemost 10:971-973.
http://www.ncbi.nlm.nih.gov/pubmed/22372829

Guerra-Shinohara EM, Bertinato JF, Tosin Bueno C, Cordeiro da Silva K, Burlacchini de Carvalho MH, Pulcineli Vieira Francisco R, . . . Morelli VM (2012) Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22918506

Hanson E, Kanse SM, Joshi A, Jood K, Nilsson S, Blomstrand C, Jern C (2012) Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke. J Thromb Haemost 10:848-856.
http://www.ncbi.nlm.nih.gov/pubmed/22409238

Hilden I, Lauritzen B, Sorensen BB, Clausen JT, Jespersgaard C, Krogh BO, . . . Bjorn SE (2012) Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood 119:5871-5878.
http://www.ncbi.nlm.nih.gov/pubmed/22563084

Hot A, Lavocat F, Lenief V, Miossec P (2012) Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells. Ann Rheum Dis.
http://www.ncbi.nlm.nih.gov/pubmed/22915623

Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, Van Rooijen N, . . . Tsutsui H (2012) Interferon gamma-mediated tissue factor expression contributes to T cell-mediated hepatitis via induction of hypercoagulation in mice. Hepatology.
http://www.ncbi.nlm.nih.gov/pubmed/22936459

Kopyta IA, Emich-Widera E, Balcerzyk A, Niemiec P, Zak I, Pilarska E, . . . Palatynska K (2012) Polymorphisms of Genes Encoding Coagulation Factors II, V, VII, and XIII in Relation to Pediatric Ischemic Stroke: Family-based and Case-Control Study. Neurologist 18:282-286.
http://www.ncbi.nlm.nih.gov/pubmed/22931734

Ledgerwood AM, Blaisdell W (2012) Coagulation challenges after severe injury with hemorrhagic shock. J Trauma Acute Care Surg 72:1714-1718.
http://www.ncbi.nlm.nih.gov/pubmed/22695446

Lo L, Valentine H, Harrison J, Hayes S, Welch I, Pritchard S, . . . Ang Y (2012) Tissue factor expression in the metaplasia-adenoma-carcinoma sequence of gastric cancer in a European population. Br J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/22929889

Ma Q, Nie X, Yu M, Wang Z, Yang S, Jia D, Zhou Y (2012) Rapamycin regulates the expression and activity of kruppel-like transcription factor 2 in human umbilical vein endothelial cells. PLoS One 7:e43315.
http://www.ncbi.nlm.nih.gov/pubmed/22937032

Mahlangu JN, Coetzee MJ, Laffan M, Windyga J, Yee TT, Schroeder J, . . . Lemm G (2012) Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia. J Thromb Haemost 10:773-780.
http://www.ncbi.nlm.nih.gov/pubmed/22353395

Maugeri N, Franchini S, Campana L, Baldini M, Ramirez GA, Sabbadini MG, . . . Manfredi AA (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity.
http://www.ncbi.nlm.nih.gov/pubmed/22928592

McVey JH (2012) Factor seven-activating protease: does it do what it says on the tin? J Thromb Haemost 10:857-858.
http://www.ncbi.nlm.nih.gov/pubmed/22394423

Miyares MA, Davis K (2012) Newer oral anticoagulants: A review of laboratory monitoring options and reversal agents in the hemorrhagic patient. Am J Health Syst Pharm 69:1473-1484.
http://www.ncbi.nlm.nih.gov/pubmed/22899742

Mlynarsky L, Bejarano-Achache I, Muszkat M, Caraco Y (2012) Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers. Eur J Clin Pharmacol 68:617-627.
http://www.ncbi.nlm.nih.gov/pubmed/22071881

Montes R, Puy C, Molina E, Hermida J (2012) Is EPCR a multi-ligand receptor? Pros and cons. Thromb Haemost 107:815-826.
http://www.ncbi.nlm.nih.gov/pubmed/22318610

Noto D, Cefalu AB, Barbagallo CM, Falletta A, Ganci A, Sapienza M, . . . Averna MR (2012) Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study. Acta Diabetol 49:145-151.
http://www.ncbi.nlm.nih.gov/pubmed/21698484

Pena E, Arderiu G, Badimon L (2012) Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22938499

Perez-Sanchez C, Ruiz-Limon P, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, . . . Lopez-Pedrera C (2012) Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment. Blood 119:5859-5870.
http://www.ncbi.nlm.nih.gov/pubmed/22529290

Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P (2012) Rare bleeding disorders. Haemophilia 18 Suppl 4:148-153.
http://www.ncbi.nlm.nih.gov/pubmed/22726099

Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, . . . Rosendaal FR (2012) Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 10:615-621.
http://www.ncbi.nlm.nih.gov/pubmed/22321862

Phillips CL, McEwen BJ, Morel-Kopp MC, Yee BJ, Sullivan DR, Ward CM, . . . Grunstein RR (2012) Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 67:639-644.
http://www.ncbi.nlm.nih.gov/pubmed/22334531

Poralla C, Hertfelder HJ, Oldenburg J, Muller A, Bartmann P, Heep A (2012) Elevated Interleukin-6 Concentration and Alterations of the Coagulation System Are Associated with the Development of Intraventricular Hemorrhage in Extremely Preterm Infants. Neonatology 102:270-275.
http://www.ncbi.nlm.nih.gov/pubmed/22906886

Reitter-Pfoertner S, Horvath B, Lechner K, Sunder-Plassmann R, Mannhalter C, Pabinger I (2012) Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challenge. Wien Klin Wochenschr 124:198-201.
http://www.ncbi.nlm.nih.gov/pubmed/22249861

Saito M, Wakasa K, Mori A, Irie T, Tanaka M, Morioka M, Ieko M (2012) [Clinical evaluation of three elderly cases with acquired hemophilia A]. Rinsho Ketsueki 53:240-245.
http://www.ncbi.nlm.nih.gov/pubmed/22450586

Salaj P, Ovesna P, Penka M, Hedner U (2012) Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22928909

Sen P, Clark CA, Gopalakrishnan R, Hedner U, Esmon CT, Pendurthi UR, Rao LV (2012) Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systems. Thromb Haemost 107:951-961.
http://www.ncbi.nlm.nih.gov/pubmed/22370814

Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012) Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-kappaB and apoptosis mediated by a caspase-3 independent pathway. Mol Biol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/22932941

Smith NL, Heit JA, Tang W, Teichert M, Chasman DI, Morange PE (2012) Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost 10:719-722.
http://www.ncbi.nlm.nih.gov/pubmed/22340074

Sovershaev MA, Egorina EM, Osterud B, Hansen JB (2012) Evidence for direct transfer of tissue factor from monocytes to platelets in whole blood. Blood Coagul Fibrinolysis 23:345-350.
http://www.ncbi.nlm.nih.gov/pubmed/22343684

Stavenuiter F, Dienava-Verdoold I, Boon-Spijker MG, Brinkman HJ, Meijer AB, Mertens K (2012) Factor seven activating protease (FSAP): does it activate factor VII? J Thromb Haemost 10:859-866.
http://www.ncbi.nlm.nih.gov/pubmed/22235940

Stephenne X, Nicastro E, Eeckhoudt S, Hermans C, Nyabi O, Lombard C, . . . Sokal E (2012) Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity. PLoS One 7:e42819.
http://www.ncbi.nlm.nih.gov/pubmed/22900053

Stollenwerk MM, Lasson A, Andersson R (2012) Active site-inactivated factor VIIa inhibits nuclear factor kappa B activation in intestinal ischemia and reperfusion. J Surg Res.
http://www.ncbi.nlm.nih.gov/pubmed/22920553

Velayudhan BT, Huderson BP, McGilliard ML, Jiang H, Ellis SE, Akers RM (2012) Effect of staged ovariectomy on measures of mammary growth and development in prepubertal dairy heifers. Animal 6:941-951.
http://www.ncbi.nlm.nih.gov/pubmed/22558965

Vincent JL, Dutton R, Parr M, Hauser C (2011) Massive bleeding in polytrauma: how can we make progress? Crit Care 15:196.
http://www.ncbi.nlm.nih.gov/pubmed/21996523

Wang HJ, Huang HC, Chuang YC, Liao PJ, Yang DM, Yang WK, Huang H (2012) Modulation of tissue factor and thrombomodulin expression in human aortic endothelial cells incubated with high glucose. Acta Diabetol 49:125-130.
http://www.ncbi.nlm.nih.gov/pubmed/20309589

Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, . . . Mackman N (2012) Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 119:5543-5552.
http://www.ncbi.nlm.nih.gov/pubmed/22547577

Winckers K, Ten Cate-Hoek AJ, Beekers KC, Erkens P, Hamulyak K, Ten Cate H, Hackeng TM (2012) Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22900482

Yamashita N, Abe R, Nixon AM, Rochier AL, Madri JA, Sumpio BE (2011) Cyclic strain delays the expression of tissue factor induced by thrombin in human umbilical vein endothelial cells. Int J Angiol 20:157-166.
http://www.ncbi.nlm.nih.gov/pubmed/22942631

Yoshihiro M, Takamiya O (2012) [The expression of recombinant factor VII variants is influenced by different cells for transfection using expression studies]. Rinsho Byori 60:193-200.
http://www.ncbi.nlm.nih.gov/pubmed/22568080

Yu YJ, Li YM, Hou XD, Guo C, Cao N, Jiao ZY (2012) Effect of tissue factor on invasion inhibition and apoptosis inducing effect of oxaliplatin in human gastric cancer cell. Asian Pac J Cancer Prev 13:1845-1849.
http://www.ncbi.nlm.nih.gov/pubmed/22901134

Zhang Q, Zhang Y, Wang SZ, Wang N, Jiang WG, Ji YH, Zhang SL (2012) Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J Exp Clin Cancer Res 31:1.
http://www.ncbi.nlm.nih.gov/pubmed/22208663

Zhou H, Chen D, Xie H, Xia L, Wang T, Yuan W, Yan J (2012) Activation of MAPKs in the anti-beta(2)GPI/beta(2)GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22940059

Zhou LL, Han Y, Zhu Q, Hu LP, Zhao SX, Zhu MQ, . . . Wu DP (2012) [Detection of tissue factor-positive microparticles and its clinical significance in the haemostatic disorder]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20:937-940.
http://www.ncbi.nlm.nih.gov/pubmed/22931659

__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________